International Journal of Infectious Diseases This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Prevalence of HTLV-1/2 infection in pregnant women in Central and South America and the Caribbean: a systematic review and meta ‑analysis
Human T-lymphotropic viruses 1 (HTLV-1) and 2 (HTLV-2) were the first identified retroviruses in humans. Both were originally isolated from patients with T-cell leukemias or lymphomas in the early eighties [1-3]. Soon thereafter, HTLV-1 was associated with the development of tropical spastic paraparesis in the Caribbean basin [4]. In contrast, HTLV-2 has only occasionally been linked to any disease since first description [5]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 22, 2024 Category: Infectious Diseases Authors: Juan-Pablo S ánchez-Núñez, Eva de-Miguel-Balsa, Vicente Soriano, Edurado Lorenzo-Garrido, Angel Giménez-Richarte, Silvia Otero-Rodriguez, Juan-Carlos Celis-Salinas, Carmen de-Mendoza, Martin Casapia-Morales, José Manuel Ramos-Rincón Source Type: research

Interplay of inflammatory markers and anti-SARS-CoV-2 antibodies in COVID-19 mortality: a prospective cohort study
coronavirus disease 2019 (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 21, 2024 Category: Infectious Diseases Authors: Sylvia Mink, Heinz Drexel, Andreas Leiherer, Matthias Frick, Patrick Reimann, Christoph H. Saely, Peter Fraunberger Source Type: research

Universal antifungal prophylaxis effectively prevents fungal bloodstream infection in pediatric liver transplant recipients: a retrospective real-world study
Fungal bloodstream infection (fBSI) is a severe systemic infection, and it ranks among the leading causes of mortality following liver transplantation, with reported mortality rates ranging from 7% to 42%[1, 2]. The prevention of fungal infection is of paramount importance, given the devastating impact they can have on post-transplantation outcomes. Currently, antifungal prophylaxis for patients underwent liver transplantation remains controversial. Some studies advocate for universal prophylaxis, with nearly 30% of liver transplantation centers in North America adopting this approach[3, 4]. (Source: International Journal ...
Source: International Journal of Infectious Diseases - March 21, 2024 Category: Infectious Diseases Authors: Weili Wang, Yangyang Wang, Yuntao Zhang, Wei Zhang, Xueli Bai, Qi Zhang, Tingbo Liang Source Type: research

Incidental diagnosis of monkeypox virus infection in patients undergoing STI screening – findings from a study in France.
Human monkeypox, a previously rare viral zoonosis, predominantly endemic to central and western Africa, emerged in May 2022 in non-endemic countries [1]. Initially confirmed in England [2], human autochthonous cases spread across 113 countries around the world, including 106 countries which had never previously reported monkeypox virus (MPXV) (https://www.cdc.gov/poxvirus/mpox/response/2022/world-map.html). Nearly 26,000 cases have been reported in Europe (https://monkeypoxreport.ecdc.europa.eu/). (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 21, 2024 Category: Infectious Diseases Authors: Sophie Edouard, C éline Boschi, Philippe Colson, Matthieu Million, Pierre-Edouard Fournier, Bernard La Scola, Florence Fenollar Tags: Short Communication Source Type: research

Joint analysis of vaccination effectiveness and antiviral drug effectiveness for COVID-19: a causal inference approach
As of July 26th, 2023, the novel coronavirus, known as severe acute respiratory syndrome coronavirus 2 (SARS ‑CoV‑2), has caused more than 768 million confirmed infection cases of COVID-19, resulting in over 6.9 million associated fatalities globally [1]. Over the course of the long battle with the COVID-19 pandemic, vaccinations [2-3] and oral antivirals [4-5] have been developed to contain the spread of the disease and reduce the risk of developing severe conditions. Although randomized controlled trials (RCTs) are the “gold standard” [6] of identifying the causal effects of COVID-19 vaccinations and oral antivir...
Source: International Journal of Infectious Diseases - March 21, 2024 Category: Infectious Diseases Authors: Yue Yat Harrison Cheung, Eric Ho Yin Lau, Guosheng Yin, Yun Lin, Jialiang Jiang, Benjamin John Cowling, Kwok Fai Lam Source Type: research

The Successful Treatment of Mpox with Brincidofovir in Renal Transplant Recipients – A report of 2 cases
Before 2022, mpox was a rare disease that belongs to the Orthopoxvirus genus [1]. The first human case was reported in 1970 in the Democratic Republic of the Congo [2]. In May 2022, a surge of mpox cases was noted in non-endemic countries leading to the world health organization (WHO) declaring a global outbreak among humans [3]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 21, 2024 Category: Infectious Diseases Authors: Reem M. Alameer, Amani Yamani, Abdulrahman Al-Saud, Sultan Alsobayeg, Bayan Alamro, Alaa Alali, Ehab Hammad, Ali M. Shendi, Reem S. Almaghrabi Tags: Case Report Source Type: research

Vaccine-derived Yellow Fever in an immunocompromised patient on anti-CD20-antibody therapy and its treatment with Sofosbuvir
Yellow fever (YF) is a potentially lethal viral hemorrhagic fever transmitted to humans by Haemagogous and Aedes spp., (mainly Aedes aegypti). The risk of a YF infection for unvaccinated people during a two week stay in West Africa is about 50:100.000 and 5:100.000 in South America. Case fatality rates reach up to 40-60% in South America but are estimated at 20% in Africa [1] ⁠. The 17D live attenuated YF vaccine, which was developed in 1937 by Max Theiler, proved to be a highly effective method in preventing an outbreak of the symptomatic disease, but can also cause severe adverse reactions like YF vaccine-associated ne...
Source: International Journal of Infectious Diseases - March 21, 2024 Category: Infectious Diseases Authors: Tobias Weirauch, Gerrit Burger, D ániel Cadar, Martin Gabriel, Julia Koepsell, Gundolf Schüttfort, Philipp de Leuw, Markus Bickel, Maria J.G.T. Vehreschild, Timo Wolf, Nils Wetzstein Tags: Case Report Source Type: research

Dynamics of Plasmodium species and genotype diversity in adults with asymptomatic infection in Gabon
With 249 million estimated cases and 608,000 deaths worldwide in 2022 [1], malaria remains a public health concern. In endemic areas, individuals can be infected by different Plasmodium species and distinct genotypes of the same species. In serially collected samples, alleles disappearance and reappearance over time was described in asymptomatic infections, raising the question of whether a single blood sample is sufficient to characterize parasite diversity within-host [2]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 16, 2024 Category: Infectious Diseases Authors: Juliana Inoue, Annika Galys, Miriam Rodi, Dorothea Ekoka Mbassi, Ghyslain Mombo-Ngoma, Ay ôla A. Adegnika, Michael Ramharter, Rella Zoleko-Manego, Peter G. Kremsner, Benjamin Mordmüller, Jana Held Source Type: research

Next-Generation Vaccines for Tropical Infectious Diseases
Tropical infectious diseases impact on the quality of life across a large proportion of the global population. To meet the objectives of the World Health Organisation (WHO) Neglected Tropical Diseases and Malaria 2021-2030 roadmaps [1], the building of widespread capacity for the successful control and elimination of tropical infectious diseases over the next decade remains crucial. Ongoing advancements in the development of novel, effective and targeted vaccines play an integral role in the success of infectious diseases management worldwide [1]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 16, 2024 Category: Infectious Diseases Authors: Tammy Allen, Maria Eugenia Castellanos, Paul Giacomin, Nadira D Karunaweera, Andreas Kupz, Juan Carlos LoL, Dileep Sharma, Suchandan Sikder, Bemnet Tedla, Liza van Eijk, Danica Vojisavljevic, Guangzu Zhao, Saparna Pai Source Type: research

Dynamics of asymptomatic Plasmodium falciparum and Plasmodium vivax infections and their infectiousness to mosquitoes in a low transmission setting of Ethiopia: a longitudinal observational study
Recent progress in malaria control has stalled in many endemic settings and gains are threatened by emerging biological, social and economic challenges [1]. Despite challenges, malaria control in Ethiopia remained on track with an aspirational target for elimination in selected low transmission settings by 2030 [2]. There is increased awareness of the widespread presence of Plasmodium infections that neither elicit acute symptoms nor treatment seeking behavior in low transmission settings [3 –5]. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 13, 2024 Category: Infectious Diseases Authors: Elifaged Hailemeskel, Surafel K. Tebeje, Jordache Ramjith, Temesgen Ashine, Kjerstin Lanke, Sinknesh W. Behaksra, Tadele Emiru, Tizita Tsegaye, Abrham Gashaw, Soria Kedir, Wakweya Chali, Endashaw Esayas, Temesgen Tafesse, Haile Abera, Mikiyas Gebremichael Source Type: research

Transformative potential of Artificial Intelligence on healthcare and research in Africa
The rise of Artificial Intelligence (AI) stands out as a revolutionary technological force, surpassing the transformative impact observed during the transition to web and mobile technologies.[1,2] Advances in technology present opportunities for enhancing scientific discovery, accelerating human progress, and improving quality of life. AI, a broad term covering machine and deep learning algorithms emulating human intelligence, has led to the development of various algorithms aiding tasks in public health, from workflow optimization to diagnostics and forecasting. (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 13, 2024 Category: Infectious Diseases Authors: Moses J Bockarie, Rashid Ansumana, Shingai Grace Machingaidze, Dziedzom K. de Souza, Patrick Fatoma, Alimuddin Zumla, Shui-Shan Lee Tags: Editorial Source Type: research

Editorial Board
(Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 12, 2024 Category: Infectious Diseases Source Type: research

Publisher's Note
(Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 12, 2024 Category: Infectious Diseases Source Type: research

Prevalence and risk factors of post-coronavirus disease 2019 condition among children and adolescents in Japan: A matched case-control study in the general population
Coronavirus disease 2019 (COVID-19), with over 769 million confirmed cases worldwide as of July 2023, 1is increasingly prevalent among children and adolescents. Children and adolescents are more likely to experience asymptomatic or milder forms of acute severe acute respiratory syndrome coronavirus 2 (SARS ‑CoV‑2) infection than adults. 2 The increasing number of infected children and adolescents raises concerns about the long-term impact of SARS-CoV-2 infection, known as post-COVID-19 condition (PPC). (Source: International Journal of Infectious Diseases)
Source: International Journal of Infectious Diseases - March 12, 2024 Category: Infectious Diseases Authors: Mariko Hosozawa, Miyuki Hori, Mina Hayama-Terada, Iba Arisa, Yoko Mutou MPH, Akihiko Kitamura, Yoshihiro Takayama, Hiroyasu Iso Source Type: research

Screening for latent tuberculosis in migrants —status quo and future challenges
It has been previously estimated that the global prevalence of latent TB infection (LTBI) is 24% of the world's population [1,2]. The World Health Organization (WHO) estimated in 2023 that 1.8 billion people are infected with Mycobacterium tuberculosis, but without clinical symptoms of active tuberculosis, which is the definition of latent TB infection [3,4]. This represents a 4.5% increase from 2020. With the COVID-19 pandemic now over, TB is once again the leading cause of death from a single infectious agent, with 1.4 million deaths among HIV-negative people and 187,000 deaths among HIV-positive people estimated in 2021...
Source: International Journal of Infectious Diseases - March 11, 2024 Category: Infectious Diseases Authors: Eskild Petersen, Seif Al-Abri, Amina Al-Jardani, Ziad A. Memish, Eleni Aklillu, Francine Ntoumi, Peter Mwaba, Christian Wejse, Alimuddin Zumla, Fatma Al-Yaquobi Tags: Review Source Type: research